Status:
UNKNOWN
Infection Tracking in Travellers. The Project Aims to Identify Profiles of Travel-associated Illness and to Follow up on Long-term Sequelae of Arboviral Infections and Malaria
Lead Sponsor:
Patricia Schlagenhauf
Collaborating Sponsors:
ETH Zurich
Swiss Tropical & Public Health Institute
Conditions:
Travel-Related Illness
Malaria
Eligibility:
All Genders
18-90 years
Brief Summary
The investigators hypothesize that sex, age, area of exposure and purpose of travel are associated with different travel-related infections. The investigators also hypothesize that certain infections ...
Detailed Description
International travel is growing exponentially. Globally, there will be a projected 1.8 billion traveller arrivals in 2030. Current surveillance of travellers' health is top-down (i.e., clinicians/labo...
Eligibility Criteria
Inclusion
- travellers who cross international borders
- adults (over 18 years old)
- those traveling for more than 2 days and less than 8 weeks
Exclusion
- Non travellers (not crossing international borders)
- Minors (under 18 years old)
- those traveling for less than 2 days and longer than 8 weeks
Key Trial Info
Start Date :
January 30 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
10000 Patients enrolled
Trial Details
Trial ID
NCT04672577
Start Date
January 30 2021
End Date
December 31 2025
Last Update
December 17 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Epidemiology, Biostatistics and Prevention Institute at the University of Zurich
Zurich, Switzerland, 8001